Keryx Biopharmaceuticals (KERX) Announces Positive Interes Results De la Phase 2 Clinical Student Pentru KRX-101 (Sulodexide Gelcaps) Pentru Treatment De Diabetic Nephropathy.

Around 40% de diabetic patients program la spre diabetic nephropathy. So departe art.hot. progression a putea a fi �nt�rziat by �nchis s�nge zah�r contract etc. Totu�i acolo is nu known cure.

�n Phase II student, 24 la sut� de la patients a primi un 200 milligram sau 400 milligram dose de sulodexide gelcaps pentru �ase lun� calendaristic� had "therapeutic victorios" compact cu 13 la sut� de aceia patients a primi un placebo.

Therapeutic victorios is defined as schimbare de la microalbuminuria la spre normoalbuminuria c�nd acolo is cel pu�in un 25 la sut� reduction �n�untru microalbuminuria sau cel pu�in un 50 la sut� reduction �n�untru albumin/creatinine ratio level.

Link